,sentence,pubmed_id,content,label,labeler
0,"50 ||| Results ||| 4.1 ||| Between Jan 6, 2012 (fi rst participant, fi rst visit), and March 15, 2013 (last participant, last visit), 4161 participants were randomly assigned to receive double-blind treatment, 4118 of whom were included in the intentionto-treat population (fi gure 1).",24881993,4161 participants,po.Size,HeYingzhi
1,"11 ||| Introduction ||| 1.9 ||| Participants were randomly assigned (2:2:2:2:2:2:2:1) to 4 weeks of double-blind treatment with a nebivolol and valsartan fi xed-dose combination (5 and 80 mg/day, 5 and 160 mg/day, or 10 and 160 mg/day), nebivolol monotherapy (5 mg/day or 20 mg/day), valsartan monotherapy (80 mg/day or 160 mg/day), or placebo.",24881993,4 weeks of double-blind treatment,i.Procedure,HeYingzhi
2,"11 ||| Introduction ||| 1.9 ||| Participants were randomly assigned (2:2:2:2:2:2:2:1) to 4 weeks of double-blind treatment with a nebivolol and valsartan fi xed-dose combination (5 and 80 mg/day, 5 and 160 mg/day, or 10 and 160 mg/day), nebivolol monotherapy (5 mg/day or 20 mg/day), valsartan monotherapy (80 mg/day or 160 mg/day), or placebo.",24881993,"nebivolol and valsartan fixed-dose combination (5 and 80 mg/day, 5 and 160 mg/day, or 10 and 160 mg/day), nebivolol monotherapy (5 mg/day or 20 mg/day), valsartan monotherapy (80 mg/day or 160 mg/day), or placebo",i.Procedure,HeYingzhi
3,"85 ||| Results ||| 4.36 ||| Finally, post-hoc and exploratory fi ndings suggest that the nebivolol and valsartan fi xed-dose combination has a haemodynamic eff ect that includes reductions in both pulse rate and pulse pressure (consistent with pharmacological properties of individual components) 10,15 and that this combination would be eff ective in a wide variety of patients.",24881993,the nebivolol and valsartan fixed-dose combination has a haemodynamic effect that includes reductions in both pulse rate and pulse pressure (consistent with pharmacological properties of individual components),o.Treatment,HeYingzhi
4,"85 ||| Results ||| 4.36 ||| Finally, post-hoc and exploratory fi ndings suggest that the nebivolol and valsartan fi xed-dose combination has a haemodynamic eff ect that includes reductions in both pulse rate and pulse pressure (consistent with pharmacological properties of individual components) 10,15 and that this combination would be eff ective in a wide variety of patients.",24881993,this combination would be effective in a wide variety of patients.,o.Patient,HeYingzhi
5,"12 ||| Introduction ||| 1.10 ||| Doses were doubled at the beginning of week 5 to fi xeddose combinations 10 and 160 mg/day, 10 and 320 mg/day, and 20 and 320 mg/day; nebivolol 10 mg/day and 40 mg/day; and valsartan 160 mg/day and 320 mg/day.",24881993,Doses were doubled at the beginning of week 5,i.Procedure,HeYingzhi
6,"28 ||| Outcomes ||| 2.2 ||| Other secondary efficacy parameters were changes from baseline in mean trough seated diastolic and systolic blood pressure at week 4 and changes in 24-h ABPM values for diastolic and systolic blood pressure from baseline to week 8 for participants assigned to the fixed dose combination of 20 and 320 mg/day versus 40 mg/day nebivolol and 320 mg/day valsartan; diastolic blood pressure responder rates at week 8 at levels less than 90 mm Hg and less than 80 mm Hg, and systolic blood pressure responder rates at week 8 at levels less than 140 mm Hg and less than 130 mm Hg (20 and 320 mg/day fi xed-dose combination versus nebivolol 40 mg/day and valsartan 320 mg/day).",24881993,systolic blood pressure responder rates at week 8 at levels less than 140 mm Hg and less than 130 mm Hg (20 and 320 mg/day fi xed-dose combination versus nebivolol 40 mg/day and valsartan 320 mg/day),i.SS,HeYingzhi
